Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA)

Trial Identifier: D7000C00001
Sponsor: AstraZeneca
NCTID:: NCT05648110
Start Date: December 2022
Primary Completion Date: November 2023
Study Completion Date: November 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
ES Majadahonda, ES, 28222
ES Marbella (Málaga), ES, 29603
ES Mérida, ES, 06800
ES Pozuelo de Alarcón, ES, 28223
GB London, GB, W1T 7HA
GB Manchester, GB, M8 5RB
GB Oxford, GB, OX3 7LA
KR Gyeonggi-do, KR, 13620
KR Seoul, KR, 03080
KR Seoul, KR, 5505
PL Krakow, PL, 30-510
PL Lublin, PL, 20-362
TW Taipei, TW, TAIWAN
US, AL Birmingham, AL, US, 35215
US, AR Little Rock, AR, US, 72205
US, CA Modesto, CA, US, 95350
US, CA Westminster, CA, US, 92683
US, CO Aurora, CO, US, 80014
US, CO Fort Collins, CO, US, 80525
US, FL Coral Gables, FL, US, 33134
US, FL Hollywood, FL, US, 33024
US, FL Lake Worth, FL, US, 33462
US, FL Lauderdale Lakes, FL, US, 33313
US, FL Medley, FL, US, 33166
US, FL Miami, FL, US, 33126
US, FL Miami, FL, US, 33135
US, FL Miami, FL, US, 33125
US, FL Miami Lakes, FL, US, 33014
US, FL North Miami Beach, FL, US, 33162
US, FL Orlando, FL, US, 32806
US, FL Ormond Beach, FL, US, 32174
US, IL Chicago, IL, US, 60640
US, IL Chicago, IL, US, 60612
US, MO Kansas City, MO, US, 64114
US, NC Charlotte, NC, US, 28207
US, NY Ridgewood, NY, US, 11385
US, PA Pittsburgh, PA, US, 15232
US, SC Rock Hill, SC, US, 29732
US, TN Knoxville, TN, US, 37909
US, TX Austin, TX, US, 78745
US, TX Houston, TX, US, 77070
US, TX Houston, TX, US, 77089
US, VA Annandale, VA, US, 22003
US, WI Madison, WI, US, 53715
ZA Newton, ZA, 2113